Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).

Torrent Pharms. Ltd. v. Merck Frosst Canada & Co., IPR2014-00559 (PTAB)

Apr. 1, 2014

N/A

Daliresp® (roflumilast tablets)

6,448,274

Bayer Pharma AG v. Par Pharm., Inc., 14-2065 (D.N.J.)

Apr. 2, 2014

Hon. Jose L. Linares

Staxyn® (vardenafil hydrochloride tablets)

8,613,950

Noven Pharms., Inc. v. Novartis AG, IPR2014-00549 (PTAB)

Apr. 2, 2014

N/A

Exelon® (rivastigmine extended-release film)

6,316,023

Noven Pharms., Inc. v. Novartis AG, IPR2014-00550 (PTAB)

Apr. 2, 2014

N/A

Exelon® (rivastigmine extended-release film)

6,335,031

Purdue Pharma L.P. v. Teva Pharms. USA, Inc., 14-2357 (S.D.N.Y.)

Apr. 3, 2014

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride extended-release tablets)

6,488,963

Otsuka Pharm. Co., Ltd. v. Hetero USA Inc., 14-0421 (D. Del.)

Apr. 4, 2014

Hon. Richard G. Andrews

Samsca® (tolvaptan tablets)

8,501,730

Reckitt Benckiser Pharms. Inc. v. Par Pharm., Inc., 14-0422 (D. Del.)

Apr. 4, 2014

Hon. Richard G. Andrews

Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)

8,475,832
8,017,150
8,603,514

Sanofi v. Alembic Pharms. Ltd., 14-0424 (D. Del.)

Apr. 4, 2014

Hon. Richard G. Andrews

Multaq® (dronedarone tablets)

7,323,493
8,318,800
8,410,167
8,602,215

Helsinn Healthcare S.A. v. Cipla Ltd., 14-0427 (D. Del.)

Apr. 7, 2014

Hon. Gregory M. Sleet

Aloxi® (palonosetron hydrochloride intravenous solution)

8,598,218
8,598,219

Mallinckrodt LLC v. Metrics, Inc., 14-2219 (D.N.J.)

Apr. 7, 2014

Hon. Susan D. Wigenton

Pennsaid® (diclofenac sodium topical solution)

8,217,078
8,546,450
8,618,164

Kowa Co., Ltd. v. Aurobindo Pharma Ltd., 14-2497 (S.D.N.Y.)

Apr. 9, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
8,557,993

Kowa Co., Ltd. v. Aurobindo Pharma Ltd., 14-2290 (D.N.J.)

Apr. 10, 2014

Hon. Peter G. Sheridan

Livalo® (pitavastatin calcium tablets)

5,856,336
8,557,993

Novartis Pharms. Corp. v. Dr. Reddy's Labs., Ltd., 14-2329 (D.N.J.)

Apr. 10, 2014

Hon. Claire C. Cecchi

Gleevec® (imatinib mesylate capsules)

RE43,932

The Medicines Co. v. Aurobindo Pharma Ltd., 14-2367 (D.N.J.)

Apr. 11, 2014

Hon. Peter G. Sheridan

Angiomax® (bivalirudin for injection)

7,582,727
7,598,343

Glenmark Generics Ltd. v. Sanofi-Aventis U.S. LLC, 14-2374 (D.N.J.)

Apr. 11, 2014

Hon. Stanley R. Chesler

DDAVP® (desmopressin acetate tablets)

7,022,340

Kowa Co., Ltd. v. Mylan, Inc., 14-2647 (S.D.N.Y.)

Apr. 14, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Eli Lilly and Co. v. Apotex Corp., 14-0586 (S.D. Ind.)

Apr. 16, 2014

Hon. Sarah Evans Barker

Effient® (prasugrel hydrochloride tablets)

8,404,703
8,569,325

Endo Pharms., Inc. v. Depomed, Inc., IPR2014-00651, -00652 (PTAB)

Apr. 17, 2014

N/A

Gralise® (gabapentin tablets)

6,723,340

Endo Pharms., Inc. v. Depomed, Inc., IPR2014-00653, -00654 (PTAB)

Apr. 17, 2014

N/A

Gralise® (gabapentin tablets)

6,340,475

Endo Pharms., Inc. v. Depomed, Inc., IPR2014-00655, -00656 (PTAB)

Apr. 17, 2014

N/A

Gralise® (gabapentin tablets)

6,635,280

Kowa Co., Ltd. v. Mylan, Inc., 14-0504 (W.D. Pa.)

Apr. 17, 2014

Hon. Arthur J. Schwab

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Kowa Co., Ltd. v. Amneal Pharms., LLC, 14-2758 (S.D.N.Y.)

Apr. 17, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
8,557,993

Kowa Co., Ltd. v. Orient Pharma Co., Ltd., 14-2759 (S.D.N.Y.)

Apr. 17, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Kowa Co., Ltd. v. Zydus Pharms. (USA) Inc., 14-2760 (S.D.N.Y.)

Apr. 17, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Hospira, Inc. v. Aurobindo Pharma Ltd., 14-0486 (D. Del.)

Apr 18, 2014

Hon. Gregory M. Sleet

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Hospira, Inc. v. Ben Venue Labs., Inc., 14-0487 (D. Del.)

Apr 18, 2014

Hon. Gregory M. Sleet

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Hospira, Inc. v. Actavis US Holding LLC, 14-0488 (D. Del.)

Apr 18, 2014

Hon. Gregory M. Sleet

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Hospira, Inc. v. Akorn, Inc., 14-2811 (N.D. Ill.)

Apr 18, 2014

Hon. Robert M. Dow, Jr.

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Hospira, Inc. v. Intas Pharms. Ltd., 14-0336 (M.D.N.C.)

Apr 18, 2014

Hon. N. C. Tilley, Jr.

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Kowa Co., Ltd. v. Amneal Pharms., LLC, 14-2488 (D.N.J.)

Apr. 18, 2014

Hon. Peter G. Sheridan

Livalo® (pitavastatin calcium tablets)

5,856,336
8,557,993

Forest Labs., Inc. v. Amneal Pharms. LLC, 14-0508 (D. Del.)

Apr. 21, 2014

Hon. Leonard P. Stark

Namenda XR® (memantine hydrochloride extended-release capsules)

5,061,703
8,039,009
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233

Amarin Pharma, Inc. v. Apotex, Inc., 14-2550 (D.N.J.)

Apr. 21, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Amarin Pharma, Inc. v. Roxane Labs., Inc., 14-2551 (D.N.J.)

Apr. 21, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Kowa Co., Ltd. v. Zydus Pharms. (USA) Inc., 14-2552 (D.N.J.)

Apr. 22, 2014

Hon. Peter J. Sheridan

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Hyperion Therapeutics, Inc. v. Par Pharm., Inc., 14-0384 (E.D. Tex.)

Apr. 23, 2014

Hon. Rodney Gilstrap

Ravicti® (glycerol phenylbutyrate oral liquid)

8,404,215
8,642,012

AbbVie, Inc. v. Hetero USA Inc., 14-0543 (D. Del.)

Apr. 24, 2014

Hon. Richard G. Andrews

Norvir® (ritonavir tablets)

8,470,347
8,399,015

Amarin Pharma, Inc. v. Apotex, Inc. 14-2958 (N.D. Ill.)

Apr. 24, 2014

Hon. James F. Holderman

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Dow Pharm. Sciences, Inc. v. Actavis, Inc., 14-2661 (D.N.J.)

Apr. 25, 2014

Hon. Stanley R. Chesler

Acanya® (clindamycin phosphate / benzoyl peroxide gel)

8,663,699

The Medicines Co. v. Exela Pharma Sciences, LLC, 14-0058 (W.D.N.C.)

Apr. 25, 2014

Hon. Richard Voorhees

Angiomax® (bivalirudin for injection)

7,582,727
7,598,343

Amarin Pharma, Inc. v. Roxane Labs., Inc., 14-0901 (N.D. Ohio)

Apr. 25, 2014

Hon. Christopher A. Boyko

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Otsuka Pharm. Co., Ltd. v. Amneal Pharms., LLC, 14-2700 (D.N.J.)

Apr. 28, 2014

Hon. Mary L. Cooper

Abilify® (aripiprazole oral solution)

8,642,600

Cephalon, Inc. v. Uman Pharma Inc., 14-0568 (D. Del.)

Apr. 30, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride powder per vial for infusion)

8,445,524
8,436,190

Celgene Corp. v. Fresenius Kabi USA, LLC, 14-0571 (D. Del.)

Apr. 30, 2014

Hon. Richard G. Andrews

Istodax® (romidepsin for injection)

7,608,280
7,611,724

Amarin Pharma, Inc. v. Dr. Reddy's Labs., Inc., 14-2760 (D.N.J.)

Apr. 30, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Cephalon, Inc. v. Uman Pharma Inc., 14-3114 (S.D.N.Y.)

May 1, 2014

Hon. Thomas P. Griesa

Treanda® (bendamustine hydrochloride powder per vial for infusion)

8,445,524
8,436,190

Senju Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 14-0579 (D. Del.)

May 2, 2014

Hon. Sue L. Robinson

Zymaxid® (gatifloxacin) ophthalmic solution)

6,333,045

Impax Labs., Inc. v. Meda Pharms., Inc., IPR2014-00731 (PTAB)

May 7, 2014

N/A

Astepro® (azelastine hydrochloride nasal spray)

8,071,073

Kowa Co., Ltd. v. Orient Pharma Co., Ltd., 14-3336 (N.D. Ill.)

May 7, 2014

Hon. Matthew F. Kennelly

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Cephalon, Inc. v. Innopharma, Inc., 14-0590 (D. Del.)

May 9, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride powder for IV)

8,609,863

Otsuka Pharm. Co., Ltd. v. Almebic Pharms. Ltd., 14-2982 (D.N.J.)

May 9, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796
8,642,760
8,518,421

Alza Corp. v. Mylan Pharms. Inc., 14-0594 (D. Del.)

May 12, 2014

Hon. Richard G. Andrews

Concerta® (methylphenidate hydrochloride)

8,163,798

Alza Corp. v. Mylan Pharms. Inc., 14-0085 (N.D.W.V.)

May 15, 2014

Hon. Irene M. Keeley

Concerta® (methylphenidate hydrochloride)

8,163,798

Celgene Corp. v. Natco Pharma Ltd., 14-3126 (D.N.J.)

May 15, 2014

Hon. Susan D. Wigenton

Revlimid® (lenalidomide capsules)

8,530,498
8,589,188
8,626,531
8,648,095

Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 14-3168 (D.N.J.)

May 16, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796
8,642,760
8,518,421

Dr. Reddy's Labs., Inc. v. Purdue Pharm. Products L.P., 14-3230 (D.N.J.)

May 20, 2014

Hon. Jose L. Linares

Intermezzo® (zolpidem tartrate sublingual tablets)

7,658,945

Jazz Pharms., Inc. v. Amneal Pharms., LLC, 14-3235 (D.N.J.)

May 20, 2014

Hon. Esther Salas

Xyrem® (sodium oxybate oral solution)

8,589,182

Alcon Research, Ltd. v. Watson Labs., Inc., 14-0647 (D. Del.)

May 20, 2014

Hon. Sue L. Robinson

Travatan Z® (travoprost ophthalmic solution)

8,268,299
8,323,630
8,388,941

Amarin Pharma, Inc. v. Watson Labs., Inc., 14-3259 (D.N.J.)

May 21, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Allergan, Inc. v. Actavis PLC, 14-0638 (E.D. Tex.)

May 22, 2014

Hon. Rodney Gilstrap

Restasis® (cyclosporine ophthalmic emulsion 0.05%)

8,633,162
8,642,556
8,648,048
8,685,930

Otsuka Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 14-3306 (D.N.J.)

May 23, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796
8,642,760

AstraZeneca AB v. Aurobindo Pharma Ltd., 14-0664 (D. Del.)

May 23, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

AstraZeneca AB v. Glenmark Generics Ltd., 14-0665 (D. Del.)

May 23, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

AstraZeneca AB v. Watson Labs., Inc., 14-0666 (D. Del.)

May 23, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

AstraZeneca AB v. Wockhardt BIO AG, 14-0667 (D. Del.)

May 23, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

RE44,186
7,951,400

AstraZeneca AB v. Watson Labs., Inc., 14-3428 (D.N.J.)

May 24, 2014

Hon. Mary L. Cooper

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

Cephalon, Inc. v. Breckenridge Pharm., Inc., 14-0671 (D. Del.)

May 27, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride powder for IV)

8,445,524
8,436,190
8,609,863

Torrent Pharms. Ltd. v. Novartis AG, IPR2014-00784 (PTAB)

May 27, 2014

N/A

Gilenya® (fingolimod capsules)

8,324,283

Pack Pharms. LLC v. Alza Corp., IPR2014-00868 (PTAB)

May 30, 2014

N/A

Glucotrol® XL (glipizide extended release tablets)

RE44,459

Forest Labs., Inc. v. Ranbaxy, Inc., 14-0686 (D. Del.)

May 30, 2014

Hon. Leonard P. Start

Namenda XR® (memantine hydrochloride extended-release capsules)

8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233

Otsuka Pharm. Co., Ltd. v. Wockhardt Bio AG, 14-3445 (D.N.J.)

May 30, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,642,760

Apotex Corp. v. ViiV Healthcare UK Ltd., IPR2014-00876 (PTAB)

June 2, 2014

N/A

Epzicom® (abacavir sulfate / lamivudine tablets) Trizivir® (abacavir sulfate / lamivudine / zidovudine tablets)

6,417,191

AstraZeneca AB v. Sun Pharma Global FZE, 14-0694 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186 7,951
400 8,628,799

AstraZeneca AB v. Teva Pharm. USA, Inc., 14-0695 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

AstraZeneca AB v. Mylan Pharms., Inc., 14-0696 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186
7,951,400
8,628,799

AstraZeneca AB v. Amneal Pharms. LLC, 14-0697 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186
7,951,400
8,628,799

AstraZeneca AB v. Apotex Corp., 14-0698 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

Gilead Sciences, Inc. v. Mylan Inc., 14-3928 (S.D.N.Y.)

June 2, 2014

Hon. Richard J. Sullivan

Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)

6,642,245
6,703,396
8,592,397

AstraZeneca Pharms. LP v. Sandoz Inc., 14-3547 (D.N.J.)

June 3, 2014

Hon. Renee Marie Bumb

Faslodex® (fulvestrant injection)

6,774,122
7,456,160
8,329,680
8,466,139

AstraZeneca AB v. Sun Pharma Global FZE, 14-3552 (D.N.J.)

June 3, 2014

Hon. Mary L. Cooper

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186
7,951,400
8,628,799

AstraZeneca AB v. Mylan Pharms., Inc., 14-0094 (N.D.W.V.)

June 3, 2014

Hon. Irene M. Keeley

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186
7,951,400
8,628,799

Mylan Pharms. Inc. v. Gilead Sciences, Inc., IPR2014-00885 (PTAB)

June 4, 2014

N/A

Stribild® (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil fumarate tablets)
Atripla® (efavirenz / emtricitabine / tenofovir disoproxil fumarate tablets)
Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
Viread® (tenofovir disoproxil fumarate tablets)

5,922,695

Mylan Pharms. Inc. v. Gilead Sciences, Inc., IPR2014-00886 (PTAB)

June 4, 2014

N/A

Stribild® (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil fumarate tablets)
Atripla® (efavirenz / emtricitabine / tenofovir disoproxil fumarate tablets)
Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
Viread® (tenofovir disoproxil fumarate tablets)

5,935,946

Mylan Pharms. Inc. v. Gilead Sciences, Inc., IPR2014-00887 (PTAB)

June 4, 2014

N/A

Stribild® (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil fumarate tablets)
Atripla® (efavirenz / emtricitabine / tenofovir disoproxil fumarate tablets)
Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
Viread® (tenofovir disoproxil fumarate tablets)

5,977,089

Mylan Pharms. Inc. v. Gilead Sciences, Inc., IPR2014-00888 (PTAB)

June 4, 2014

N/A

Stribild® (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil fumarate tablets)
Atripla® (efavirenz / emtricitabine / tenofovir disoproxil fumarate tablets)
Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
Viread® (tenofovir disoproxil fumarate tablets)

6,043,230

Helsinn Healthcare S.A. v. Mylan, Inc., 14-0709 (D. Del.)

June 4, 2014

Hon. Gregory M. Sleet

Aloxi® (palonosetron hydrochloride intravenous solution)

7,947,724
7,947,725
7,960,424
8,598,219
8,729,094

Amarin Pharma, Inc. v. Teva Pharms. USA, Inc., 14-3558 (D.N.J.)

June 4, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Bristol-Myers Squibb Co. v. Aurobindo Pharma U.S.A., Inc., 14-3585 (D.N.J.)

June 4, 2014

Hon. Mary L. Cooper

Reyataz® (atazanavir sulfate capsules)

6,087,383

AstraZeneca AB v. Apotex Corp., 14-61309 (S.D. Fla.)

June 4, 2014

Hon. William P. Dimitrouleas

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

Teva Women's Health v. Lupin Ltd., 14-4055 (S.D.N.Y.)

June 4, 2014

Hon. Lorna G. Schofield

Quartette® (levonorgestrel / ethinyl estradiol tablets)

8,415,332
8,450,299

Warner Chilcott Co., LLC v. Amneal Pharms. LLC, 14-0718 (D. Del.)

June 6, 2014

Hon. Gregory M. Sleet

Enablex® (darifenacin hydrobromide extended-release tablets)

6,106,864

Warner Chilcott Co., LLC v. Lupin Atlantis Holdings S.A., 14-1827 (D. Md.)

June 6, 2014

Hon. Roger W. Titus

Minastrin® 24 Fe (ethinyl estradiol / norethindrone acetate tablets)

6,667,050

Cipher Pharms. Inc. v. Actavis Labs. FL, Inc., 14-3653 (D.N.J.)

June 6, 2014

Hon. Joseph E. Irenas

Absorica® (isotretinoin capsules)

7,435,427

Amarin Pharma, Inc. v. Teva Pharms. USA, Inc., 14-3251 (E.D. Pa.)

June 6, 2014

Hon. Nitza I. Quinones Alejandro

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Gilead Sciences, Inc. v. Mylan Inc., 14-0099 (N.D.W.V.)

June 9, 2014

Hon. Irene M. Keeley

Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)

6,642,245
6,703,396
8,592,397

Vivus, Inc. v. Actavis Labs. FL, Inc., 14-3786 (D.N.J.)

June 12, 2014

Hon. Faith S. Hochberg

Qsymia® (phentermine / topiramate extended-release capsules)

7,056,890
7,553,818
7,659,256
7,674,776
8,580,298
8,580,299

Alza Corp. v. Sandoz Inc., 14-0744 (D. Del.)

June 13, 2014

Hon. Richard G. Andrews

Concerta® (methylphenidate hydrochloride extended-release tablets)

8,163,798
8,629,179

Vanda Pharms. Inc. v. Roxane Labs., Inc., 14-0757 (D. Del.)

June 16, 2014

Hon. Gregory M. Sleet

Fanapt® (iloperidone tablets)

8,586,610

Alza Corp. v. Sandoz Inc., 14-3838 (D.N.J.)

June 13, 2014

Hon. Joseph E. Irenas

Concerta® (methylphenidate hydrochloride extended-release tablets)

8,163,798
8,629,179

Novartis AG v. Glenmark Pharms., Ltd., 14-0771 (D. Del.)

June 18, 2014

Hon. Leonard P. Stark

Myfortic® (mycophenolate sodium delayed-release tablets)

6,025,391
6,172,107
6,306,900

Merck Sharp & Dohme Corp. v. Fresenius Kabi USA, LLC, 14-3917 (D.N.J.)

June 18, 2014

Hon. Peter G. Sheridan

Emend® (fosaprepitant dimeglumine for injection)

5,691,336

Amarin Pharma, Inc. v. Andrx Labs., LLC, 14-3924 (D.N.J.)

June 18, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Spectrum Pharms., Inc. v. Ben Venue Labs., Inc., 14-0980 (D. Nev.)

June 18, 2014

Hon. Gloria M. Navarro

Fusilev® (levoleucovorin calcium for injection)

6,500,829

Cephalon, Inc. v. Actavis Labs. FL, Inc., 14-0776 (D. Del.)

June 19, 2014

Hon. Sue L. Robinson

Fentora® (fentanyl buccal tablets)

6,200,604
6,264,981
8,119,158

Novartis Pharms. Corp. v. Mylan Inc., 14-0777 (D. Del.)

June 19, 2014

Hon. Richard G. Andrews

Exelon® (rivastigmine transdermal system or extended-release film)

6,316,023
6,335,031

Allos Therapeutics, Inc. v. Teva Pharms. USA, Inc., 14-0778 (D. Del.)

June 19, 2014

Hon. Richard G. Andrews

Folotyn® (pralatrexate for injection)

6,028,071
7,622,470
8,299,078

Pfizer Inc. v. CFT Pharms. LLC, 14-0781 (D. Del.)

June 19, 2014

Hon. Sue L. Robinson

Tygacil® (tigecycline injectable IV infusion)

7,879,828
8,372,995

Cephalon, Inc. v. Actavis Labs. FL, Inc., 14-3936 (D.N.J.)

June 19, 2014

Hon. Stanley R. Chesler

Fentora® (fentanyl buccal tablets)

6,200,604
6,264,981
8,119,158

Janssen Pharms., Inc. v. Roxane Labs., Inc., 14-3941 (D.N.J.)

June 19, 2014

Hon. Claire C. Cecchi

Nucynta® (tapentadol hydrochloride extended-release tablets)

RE39,593
7,994,364
8,536,130

Teva Women's Health, Inc. v. Watson Labs., Inc., 14-4439 (S.D.N.Y.)

June 19, 2014

Hon. John G. Koeltl

Quartette® (levonorgestrel / ethinyl estradiol tablets)

8,415,332
8,450,299

Otsuka Pharm. Co., Ltd. v. Par Pharm., Inc., 14-0789 (D. Del.)

June 20, 2014

Hon. Richard G. Andrews

Samsca® (tolvaptan tablets)

5,753,677
8,501,730

Avanir Pharms., Inc. v. Ranbaxy Labs. Ltd., 14-0792 (D. Del.)

June 20, 2014

Hon. Leonard P. Stark

Nuedexta® (dextromethorphan hydrobromide / quinidine sulfate capsules)

7,659,282
8,227,484

Senju Pharm. Co., Ltd. v. Metrics, Inc., 14-3962 (D.N.J.)

June 20, 2014

Hon. Jerome B. Simandle

Prolensa® (bromfenac ophthalmic solution)

8,129,431
8,669,290
8,754,131

Otsuka Pharm. Co., Ltd. v. Intas Pharms. Ltd., 14-3996 (D.N.J.)

June 20, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796
8,642,760

Pfizer Inc. v. CFT Pharms. LLC, 14-0714 (E.D. Wis.)

June 20, 2014

Hon. William E. Duffin

Tygacil® (tigecycline injectable IV infusion)

7,879,828
8,372,995

Novartis Pharms. Corp. v. Mylan Inc., 14-0106 (N.D.W.V.)

June 20, 2014

Hon. Irene M. Keeley

Exelon® (rivastigmine transdermal system or extended-release film)

6,316,023
6,335,031

Biodelivery Sciences Int'l, Inc. v. RB Pharms. Ltd., IPR2014-00998 (PTAB)

June 20, 2014

N/A

Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)

8,475,832

Amneal Pharms., LLC v. Jazz Pharms., Inc., CBM2014-00149 (PTAB)

June 24, 2014

N/A

Xyrem® (sodium oxybate oral solution)

7,895,059

Novartis Pharms. Corp. v. Mylan Inc., 14-0820 (D. Del.)

June 25, 2014

Hon. Richard G. Andrews

Exjade® (deferasirox tablets for oral suspension)

6,465,504
6,596,750

Shire LLC v. Ranbaxy Labs. Ltd., 14-0827 (D. Del.)

June 25, 2014

Hon. Richard G. Andrews

Intuniv® (guanfacine hydrochloride extended-release tablets)

6,287,599
6,811,794

Orexo AB v. Actavis Elizabeth LLC, 14-0829 (D. Del.)

June 26, 2014

Hon. Sue L. Robinson

Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride dihydrate sublingual tablets)

8,454,996
8,470,361
8,658,198

Eli Lilly and Co. v. Panacea Biotec, Ltd., 14-1064 (S.D. Ind.)

June 26, 2014

Hon. Sarah Evans Barker

Effient® (prasugrel hydrochloride tablets)

8,404,703
8,569,325

Senju Pharm. Co., Ltd. v. Lupin, Ltd., 14-4149 (D.N.J.)

June 26, 2014

Hon. Jerome B. Simandle

Prolensa® (bromfenac ophthalmic solution)

8,669,290

Novartis Pharms. Corp. v. Mylan Inc., 14-0111 (N.D.W.V.)

June 26, 2014

Hon. Irene M. Keeley

Exjade® (deferasirox tablets for oral suspension)

6,465,504
6,596,750

Metrics, Inc. v. Senju Pharm. Co., Ltd., IPR2014-01041 (PTAB)

June 26, 2014

N/A

Prolensa® (bromfenac ophthalmic solution)

8,129,431

Metrics, Inc. v. Senju Pharm. Co., Ltd., IPR2014-01043 (PTAB)

June 26, 2014

N/A

Prolensa® (bromfenac ophthalmic solution)

8,669,290

Forest Labs., Inc. v. Aurobindo Pharma USA Inc., 14-0833 (D. Del.)

June 27, 2014

Hon. Leonard P. Stark

Namenda® (memantine hydrochloride tablets)

5,061,703

UCB, Inc. v. Apotex Corp., 14-0834 (D. Del.)

June 27, 2014

Hon. Leonard P. Stark

Vimpat® (lacosamide oral solution)

RE38,551

Par Pharm., Inc. v. Novartis Pharms. Corp., 14-0843 (D. Del.)

June 27, 2014

Hon. Richard G. Andrews

Exelon® (rivastigmine transdermal system or extended-release film)

6,316,023

AstraZeneca AB v. Par Pharm., Inc., 14-0845 (D. Del.)

June 30, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.